Legal Opinion
In re Stemline Therapeutics, Inc. Sec. Litig.
District Court, S.D. Illinois
Decided March 15, 2018No. 17 Civ. 832 (PAC)PublishedCited by 2 opinions
1Opinion of the Court
HONORABLE PAUL A. CROTTY, United States District Judge:
This is a securities case brought by buyers of stock in Stemline Therapeutics, Inc. ("Stemline"), which develops a highly sophisticated and complicated drug for the treatment of an otherwise fatal blood cancer. The buyers contend they were misled by Stemline's claimed ability to remediate certain fatal side effects of its drug.
Lead Plaintiffs Adam Ludlow, Daljit Singh, and Kenneth Walsh, and Representative Plaintiff Marion Beeler ("Plaintiffs") bring this consolidated class action1 against Stemline, its officers and directors, *545Ivan…
2Cases cited18 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- ECA, Local 134 IBEW Joint Pension Trust of Chicago v. JP Morgan Chase Co.Court of Appeals for the Second Circuit · 2009
- Omnicare, Inc. v. Laborers Dist. Council Constr. Industry Pension FundSupreme Court of the United States · 2015
13 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Caron v. TD AmeritradeDistrict Court, S.D. New York · 2020
- McIntosh v. Katapult Holdings, Inc.District Court, S.D. New York · 2023